Johnny Stilou

Acting CEO & Chief Financial Officer at Scandion Oncology - N/A, N/A, DK

Johnny Stilou's Colleagues at Scandion Oncology
Jane Hinrichsen

Medical Laboratory Technician

Contact Jane Hinrichsen

Maj Hedtjärn

COO and Head of R&D Operations

Contact Maj Hedtjärn

Jan Stenvang

CTO Scandion Oncology

Contact Jan Stenvang

Peter Vestlev

Distinguished Medical Scientist

Contact Peter Vestlev

View All Johnny Stilou's Colleagues
Johnny Stilou's Contact Details
HQ
N/A
Location
Company
Scandion Oncology
Johnny Stilou's Company Details
Scandion Oncology logo, Scandion Oncology contact details

Scandion Oncology

N/A, N/A, DK • 5 - 9 Employees
BioTech/Drugs

Scandion Oncology A/S is a listed Danish biotechnology company with the mission to address one of the most important challenges in modern oncology - the effective treatment of cancer which has developed resistance towards existing cancer medicine. The company's first-in-class lead compound, SCO-101, is an add-on to chemotherapy and is currently in clinical phase I and II studies in cancer patients. The company also has several preclinical programs to build a broader pipeline of drugs for the treatment of drug resistant cancer diseases.

N/A
Details about Scandion Oncology
Frequently Asked Questions about Johnny Stilou
Johnny Stilou currently works for Scandion Oncology.
Johnny Stilou's role at Scandion Oncology is Acting CEO & Chief Financial Officer.
Johnny Stilou's email address is ***@scandiononcology.com. To view Johnny Stilou's full email address, please signup to ConnectPlex.
Johnny Stilou works in the Research industry.
Johnny Stilou's colleagues at Scandion Oncology are Haatisha Jandu, Jane Hinrichsen, Maj Hedtjärn, Marc Bechmann, Jan Stenvang, Peter Vestlev and others.
Johnny Stilou's phone number is N/A
See more information about Johnny Stilou